| Financial Year |
March 31 2023 |
| Monetary Funds |
603,471,973.91 |
| Held-for-trading Financial Assets |
579,089,967.17 |
| Notes Receivable |
74,495,055.34 |
| Accounts Receivable |
352,689,653.77 |
| Advances to Suppliers |
24,787,830.10 |
| Other Receivables |
764,614,825.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
361,149,793.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,430,093.71 |
| Total Current Assets |
2,838,606,195.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
678,077,319.81 |
| Investment Properties |
111,799,830.79 |
| Fixed Assetes |
1,575,556,730.79 |
| Under-construction Projects |
1,129,576,784.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
466,530,613.67 |
| R&D expenses |
170,306,277.76 |
| Goodwill |
218,243,863.49 |
| Long-Term Deferred and Prepaid Expenses |
30,240,456.53 |
| Deferred Income Tax Assets |
130,541,332.20 |
| Other Non-Current Assets |
9,130,000.49 |
| Sub-Total of Non-Current Assets |
4,849,485,267.25 |
| Total Assets |
7,688,091,462.88 |
| Short-Term Loans |
2,221,477,785.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
117,850,624.80 |
| Accounts Payable |
480,230,474.97 |
| Accounts Received In Advance |
330,760.95 |
| Employee Compensation Payable |
19,536,087.64 |
| Taxes Payable |
16,151,910.96 |
| Interest Payable |
6,850,325.15 |
| Dividend Payable |
3,975,170.80 |
| Other payables |
578,930,136.96 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
510,246,508.24 |
| Other Current Liabilities |
3,098,885.31 |
| Sub-Total of Current Liabilities |
3,980,990,648.71 |
| Long-term Loans |
1,005,057,222.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
17,765,821.90 |
| Special Payable |
-- |
| Estimatied Liabilities |
157,817,263.91 |
| Deferred Income Tax Liabilities |
24,449,385.00 |
| Other Non-Current Liabilities |
93,000,000.00 |
| Sub-Total of Non-Current Liabilities |
1,370,608,787.42 |
| Total Liabilities |
5,351,599,436.13 |
| Paid-In Capital(Or Share Stock) |
1,297,365,126.00 |
| Capital Surplus |
2,808,402,778.99 |
| Surplus Reserve |
90,919,423.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,993,102,378.39 |
| Minority Stockholder's Interest |
168,239,309.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,168,252,717.37 |
| Owner's Equity（Stockholder's Equity） |
2,336,492,026.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,688,091,462.88 |
